People and Business News — 4/22
People News
COTA, Inc. appointed Miruna Sasu, PhD as president and chief executive
officer.
AiCure has hired Andre Paredes, PhD, as Director of OpenDBM Community, Sarah Kark, PhD, as Senior Digital Neuroscientist, and Sondra Pepe, as VP of Product Operations.
CluePoints has appointed Catherine Ditzler as VP Marketing while Céline Daubresse joins as VP People, and James Faust as the new VP Business Operations.
Suvoda expanded its leadership team with the additions of Andrew McVeigh as Chief Architect and Steve DeSantisas Chief Financial Officer.
Qlucore appointed Erik Söderbäck as head of diagnostics sales.
BioIVT announced the appointment of Jennifer Murphy as Senior Vice President of Global Commercial Operations.
Business News
Daelight Solutions renewed its Preferred certification status for Implementation Support and Business Process/Strategy services for Veeva’s Vault eTMF.
ActiGraph joined the Decentralized Trials & Research Alliance.
Medidata announced Labcorp has selected their technology platform to extend their 14-year partnership.
AiCure opened its first international office in Nanjing, China.
Recognition
Proxima Clinical Research was named to the Inc. Regionals 2022 Southwest list of the Fastest-Growing Private Companies; and was recognized by the Houston Business Journal as a company to watch, as noted in its inaugural Houston Inno Fire Awards.
Thermo Fisher Scientific won a 2021 TOPRA Award for Regulatory Excellence.
CluePoints won the Citeline Award for Excellence in Innovation in Response to COVID-19 – Clinical Trial Activities.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Grants Ziftomenib with Breakthrough Therapy Designation for NPM1-Mutant Acute Myeloid Leukemia
April 23rd 2024Data from the Phase Ib portion of the KOMET-001 trial showed that the once-daily oral treatment may provide a substantial improvement over available therapies for relapsed/refractory NPM1-mutant acute myeloid leukemia.
